A promising new treatment approach for major depressive disorder (MDD) targets the
microbiota-gut-brain (MGB) axis, which is linked to physiological and behavioral functions affected …

Depression is a debilitating disorder, and at least one third of patients do not respond to
therapy. Associations between gut microbiota and depression have been observed in recent …

Background: In major depressive disorder (MDD), cognitive dysfunctions strongly contribute
to functional impairments but are barely addressed in current therapies. Novel treatment …

Background Probiotics are suggested to improve depressive symptoms via the microbiota-gut-brain
axis. We have recently shown a beneficial clinical effect of probiotic supplementation …

Anhedonia has been associated with abnormal reward-related striatal dopamine functioning
in patients with different psychiatric disorders. Here, we tested whether anhedonia …

Background Patients with major depressive disorder (MDD) often experience relapses
despite regular treatment with pharmacotherapy and psychotherapy. Further, long waiting lists …

Although research demonstrates the importance of napping for health and well-being within
work settings, the topic has resulted in limited empirical investigations, fragmented literary …

We recently indicated that four-week probiotic supplementation significantly reduced
depression along with microbial and neural changes in people with depression. Here we further …

OBJECTIVE: The study goal was to determine whether prior outpatient exposure to hospice
discussion altered the inpatient course and end-of-life (EOL) care among patients ultimately …

Background The A-allele of the single nucleotide polymorphism (SNP), rs9939609, in the
FTO gene is associated with increased fatness. We hypothesized that the SNP is associated …